Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2008
11/13/2008CA2684703A1 Bicyclic compound and pharmaceutical use thereof
11/13/2008CA2684693A1 9-(pyrazol-3-yl)-9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatmentof cancer
11/13/2008CA2666179A1 Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease
11/12/2008EP1990413A1 Screening method for candidate drugs
11/12/2008EP1990410A1 IMMUNOTHERAPY BY USING CELL CAPABLE OF CO-EXPRESSING TARGET ANTIGEN AND CD1d AND PULSED WITH CD1d LIGAND
11/12/2008EP1990346A2 Process for the preparation of narcistatin prodrugs
11/12/2008EP1990343A2 Azaindoles
11/12/2008EP1990342A1 Pyridopyrazine Derivatives, Process of Manufacturing and Uses thereof
11/12/2008EP1990337A1 Quinazoline derivatives,preparation methods and uses thereof
11/12/2008EP1990059A2 Methods for treating cancer
11/12/2008EP1990058A1 Aglyco products and their use for inhibiting infection by influenza virus, and useof hexosamine precursor in schizophrenia treatment
11/12/2008EP1990054A1 Polymerase inhibitors and their use in treating tumours
11/12/2008EP1989233A1 Cytotoxicity mediation of cells evidencing surface expression of cd44
11/12/2008EP1989232A1 Cytotoxicity mediation of cells evidencing surface expression of cd59
11/12/2008EP1989231A2 Combinatorial therapy involving alpha5beta1 antagonists
11/12/2008EP1989230A2 Anti-fgf19 antibodies and methods using same
11/12/2008EP1989212A2 Treatment of hyperproliferative diseases with vinca alkaloid n-oxide and analogs
11/12/2008EP1989207A1 Crystalline forms of (3r,4r)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methol]piperidin-3-ol
11/12/2008EP1989206A2 Inhibitors of e1 activating enzyme
11/12/2008EP1989205A2 Thiophene-carboxamides useful as inhibitors of protein kinases
11/12/2008EP1989204A1 Pyrazoloquinolones are potent parp inhibitors
11/12/2008EP1989201A1 Pi-3 kinase inhibitors and methods of their use
11/12/2008EP1989198A1 2,4-diaminopyrimidine derivatives for the treatment and/or prevention of cancer, infections, inflammatory and autoimmune disorders
11/12/2008EP1988926A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
11/12/2008EP1988894A1 Rapamycin derivatives for treating neuroblastoma
11/12/2008EP1988877A2 Therapeutic compositions comprising ingenol-3-angelate
11/12/2008EP1718623B1 Compounds as inhibitors of cell proliferation and viral infections
11/12/2008EP1561759B1 Cell death-inducing agent
11/12/2008EP1532117B1 Multi-substituded imidazolines and method of use thereof
11/12/2008EP1523488B1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
11/12/2008EP1478659B1 Biologically active peptides
11/12/2008EP1465912B1 Chimeric tnf ligands
11/12/2008EP1424894B1 Inhibition of pathological angiogenesis in vivo
11/12/2008EP1231935B1 Attenuation of angiogenesis by use of chondroitin sulfate degrading enzymes
11/12/2008EP1147179B1 Human liver progenitors
11/12/2008EP1064551B1 Development of human monoclonal antibodies and uses thereof
11/12/2008EP1055426B1 Dysuria remedies
11/12/2008EP0950103B1 Survivin, a protein that inhibits cellular apoptosis, and its modulation
11/12/2008EP0750668B1 Novel muteins of ifn-beta
11/12/2008CN101305010A Raf inhibitor compounds and methods of use thereof
11/12/2008CN101305000A 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of C-FMS kinase
11/12/2008CN101304998A 7-substituted aza-indazoles, compositions containing same, production method and use thereof
11/12/2008CN101304996A Pyrimidine derivatives for the inhibition of IGF-1R tyrosine kinase activity
11/12/2008CN101304991A Indole derivatives as antitumoural compounds
11/12/2008CN101304990A Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof
11/12/2008CN101304985A Thiazole compounds and their use as PGD2 antagonists
11/12/2008CN101304978A Quinazoline derivatives as a multiplex inhibitor and method for the preparation thereof
11/12/2008CN101304899A Warning system
11/12/2008CN101304761A Treatment with an oncolytic virus and an immunostimulant for in vivo enhancement of immune system recognition of neoplasms
11/12/2008CN101302515A Human antibodies that bind human TNF(alpha)
11/12/2008CN101302511A Nucleic acid molecule NRN1SR12 and use thereof in anti-cancer medicine preparation
11/12/2008CN101302510A Nucleic acid molecule and use thereof in anti-cancer medicine preparation
11/12/2008CN101302501A PEGylated uricoxidase compound, preparing method, preparation and use thereof
11/12/2008CN101302490A Method for reforming lidamycin-producing bacteria by means of gene substitution technology
11/12/2008CN101302467A Tuckahoe wine
11/12/2008CN101302275A Method for preparing copolymer aquagel having cyclodextrin structure by electron beam radiation
11/12/2008CN101302256A Novel recombinant fusion molecule and antineoplastic treatment function thereof
11/12/2008CN101302249A Self-assembly short peptide and use thereof in antineoplastic medicine preparation
11/12/2008CN101302244A Production process of betulinic acid
11/12/2008CN101302243A 11-brominated-12-oleanane type pentacyclic triterpenoid and application thereof
11/12/2008CN101302236A Novel method for synthesizing antineoplastic medicine nedaplatin
11/12/2008CN101302235A Purification of picoplatin
11/12/2008CN101302208A Compound inhibiting glutathion S-transferase activity, preparation and use thereof
11/12/2008CN101302204A Quinazolone compound, composition and application including the same
11/12/2008CN101302203A 6-aryl aminopyrimidine compound and synthetic method thereof
11/12/2008CN101302199A Guidemycin and use thereof in tumor treatment
11/12/2008CN101302192A Prodrug forms of ribonucleotide reductase inhibitors 3-AP and 3-AMP
11/12/2008CN101302184A Indoline sulfanilamide compound
11/12/2008CN101302170A Optical activity (+) or (-)-gossypol derivates, preparation and use thereof
11/12/2008CN101301478A G-tetrad oligonucleotide using hypoxia inducible factor 1-alpha (HIFI alpha) as target
11/12/2008CN101301472A Anticancer composition containing taxane medicament and bortezomib
11/12/2008CN101301471A Anticancer composition containing antimetabolism medicament and bortezomib
11/12/2008CN101301470A Anticancer composition containing neovascularization inhibitor and bortezomib
11/12/2008CN101301469A Anticancer composition containing nitrosourea medicament and bortezomib
11/12/2008CN101301456A Compound Marsdenia tenacissima capsules
11/12/2008CN101301436A Food and medicament dual-purpose type red wine for preventing and treating cancer
11/12/2008CN101301431A Chinese medicine for dispersing swelling and resolving tumor and preparation thereof
11/12/2008CN101301413A Cordyceps sinensis and Rhodiola rosea capsules and preparation thereof
11/12/2008CN101301352A Chinese medicinal preparation for treating cancer and preparation
11/12/2008CN101301316A Compound formulation containing lactobacillus leavening and preparation and use thereof
11/12/2008CN101301313A Composition for treating malignant solid tumors and preparation thereof and use
11/12/2008CN101301309A Further novel forms of interfering RNA molecules
11/12/2008CN101301289A Uses of berberine and analog thereof in pump for reversing multidrug resistance
11/12/2008CN101301273A Anticancer composition containing satraplatin
11/12/2008CN101301266A Anticancer gel sustained-release injection containing alkyl agent
11/12/2008CN101301265A Dual sustained-release anticancer gel injection
11/12/2008CN101301264A Dual sustained-release anticancer injection
11/12/2008CN100432212C Grifola frondosa strain, culture method and application thereof
11/12/2008CN100432107C Protein for promoting erythrocyte growth factor activity and its use
11/12/2008CN100432103C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells.
11/12/2008CN100432094C Medicament for inhibiting tumour growth
11/12/2008CN100432076C Camptothecine derivative, preparing method and use
11/12/2008CN100432072C Salts and polymorphs of a pyrrole-substituted indolinone compound
11/12/2008CN100432071C Substituted 1H-indole-2-ketone compound and its preparation method and uses
11/12/2008CN100432070C Novel sulfamides and their use as endothelin receptor antagonists
11/12/2008CN100432065C Lactone monomer compound and its application in preparing anticancer medicine
11/12/2008CN100432062C Terphenyl derivatives, preparation thereof, compositions containing same
11/12/2008CN100432055C Tricyclic protein kinase inhibitors
11/12/2008CN100431613C Two kinds of novel angiogenesis-inhibiting medicine and its uses in preventing and treating tumour
11/12/2008CN100431610C Amphiphilic tri-block copolymer-paclitaxel bonded drug and preparation method thereof
1 ... 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 ... 2211